| Lastest Insider Transactions Of Travere Therapeutics, Inc. ( TVTX ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2025-05-02 | Sell | 1,784 | 21.05 | 37,553 | 2025-05-05 21:54:31 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2025-05-02 | Option Exercise | 4,920 | 0.00 | 0 | 2025-05-05 21:54:31 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | CHIEF EXECUTIVE OFFICER | 2025-05-02 | Sell | 18,924 | 21.05 | 398,350 | 2025-05-05 21:53:47 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | CHIEF EXECUTIVE OFFICER | 2025-05-02 | Option Exercise | 18,924 | 0.00 | 0 | 2025-05-05 21:53:47 |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | CHIEF COMMERCIAL OFFICER | 2025-05-02 | Sell | 1,771 | 21.05 | 37,280 | 2025-05-05 21:53:07 |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | CHIEF COMMERCIAL OFFICER | 2025-05-02 | Option Exercise | 4,920 | 0.00 | 0 | 2025-05-05 21:53:07 |
| TVTX | Travere Therapeutics, Inc. | ROTE WILLIAM E. | Chief Research Officer | 2025-05-02 | Sell | 3,198 | 21.05 | 67,318 | 2025-05-05 21:52:22 |
| TVTX | Travere Therapeutics, Inc. | ROTE WILLIAM E. | Chief Research Officer | 2025-05-02 | Option Exercise | 4,920 | 0.00 | 0 | 2025-05-05 21:52:22 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | Chief Legal Officer and GC | 2025-05-02 | Sell | 4,920 | 21.05 | 103,566 | 2025-05-05 21:51:34 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | Chief Legal Officer and GC | 2025-05-02 | Option Exercise | 4,920 | 0.00 | 0 | 2025-05-05 21:51:34 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2025-04-11 | Sell | 48 | 13.14 | 631 | 2025-04-14 18:23:30 |
| TVTX | Travere Therapeutics, Inc. | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | 2025-02-10 | Sell | 5,200 | 23.53 | 122,356 | 2025-02-12 21:30:01 |
| TVTX | Travere Therapeutics, Inc. | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | 2025-02-10 | Option Exercise | 8,000 | 0.00 | 0 | 2025-02-12 21:30:01 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | 2025-02-10 | Sell | 8,000 | 23.53 | 188,240 | 2025-02-12 21:28:28 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | 2025-02-10 | Option Exercise | 8,000 | 0.00 | 0 | 2025-02-12 21:28:28 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2025-02-11 | Sell | 54,244 | 25.00 | 1,356,100 | 2025-02-12 21:27:02 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2025-02-11 | Option Exercise | 45,000 | 16.63 | 748,200 | 2025-02-12 21:27:02 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2025-02-11 | Sell | 54,244 | 25.00 | 1,356,100 | 2025-02-12 21:27:02 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2025-02-11 | Option Exercise | 45,000 | 16.63 | 748,200 | 2025-02-12 21:27:02 |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | CHIEF COMMERCIAL OFFICER | 2025-02-10 | Sell | 5,642 | 24.33 | 137,276 | 2025-02-12 21:25:32 |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | CHIEF COMMERCIAL OFFICER | 2025-02-10 | Option Exercise | 8,000 | 0.00 | 0 | 2025-02-12 21:25:32 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | CHIEF EXECUTIVE OFFICER | 2025-02-11 | Sell | 11,375 | 24.04 | 273,455 | 2025-02-12 21:23:43 |
| TVTX | Travere Therapeutics, Inc. | Inrig Jula | CHIEF MEDICAL OFFICER | 2025-02-10 | Sell | 2,568 | 23.53 | 60,426 | 2025-02-12 21:22:15 |
| TVTX | Travere Therapeutics, Inc. | Inrig Jula | CHIEF MEDICAL OFFICER | 2025-02-10 | Option Exercise | 8,000 | 0.00 | 0 | 2025-02-12 21:22:15 |
| TVTX | Travere Therapeutics, Inc. | Baynes Roy D. | Directior | 2025-02-06 | Sell | 10,000 | 22.00 | 220,000 | 2025-02-10 18:04:17 |
| TVTX | Travere Therapeutics, Inc. | Baynes Roy D. | Directior | 2025-02-06 | Option Exercise | 10,000 | 17.44 | 174,400 | 2025-02-10 18:04:17 |
| TVTX | Travere Therapeutics, Inc. | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | 2025-01-31 | Sell | 8,951 | 19.78 | 177,051 | 2025-02-04 20:30:29 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | 2025-01-31 | Sell | 8,951 | 19.78 | 177,051 | 2025-02-04 20:30:25 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | CHIEF EXECUTIVE OFFICER | 2025-01-31 | Sell | 50,691 | 20.21 | 1,024,343 | 2025-02-04 20:30:21 |
| TVTX | Travere Therapeutics, Inc. | Inrig Jula | CHIEF MEDICAL OFFICER | 2025-01-31 | Sell | 5,273 | 20.12 | 106,082 | 2025-02-04 20:30:18 |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | CHIEF COMMERCIAL OFFICER | 2025-01-31 | Sell | 5,166 | 20.12 | 103,940 | 2025-02-04 20:30:15 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2025-01-31 | Sell | 5,192 | 20.12 | 104,463 | 2025-02-04 20:30:11 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2025-01-31 | Sell | 3,348 | 20.12 | 67,362 | 2025-02-04 20:30:07 |
| TVTX | Travere Therapeutics, Inc. | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | 2025-01-22 | Sell | 2,437 | 19.46 | 47,424 | 2025-01-23 20:40:03 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | CHIEF EXECUTIVE OFFICER | 2025-01-22 | Sell | 10,736 | 19.46 | 208,923 | 2025-01-23 20:39:00 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | 2025-01-22 | Sell | 2,437 | 19.46 | 47,424 | 2025-01-23 20:37:55 |
| TVTX | Travere Therapeutics, Inc. | Baynes Roy D. | Directior | 2025-01-23 | Sell | 16,000 | 20.00 | 320,000 | 2025-01-23 20:36:55 |
| TVTX | Travere Therapeutics, Inc. | Baynes Roy D. | Directior | 2025-01-23 | Option Exercise | 16,000 | 17.50 | 280,000 | 2025-01-23 20:36:55 |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | CHIEF COMMERCIAL OFFICER | 2025-01-22 | Sell | 1,584 | 18.94 | 30,002 | 2025-01-23 20:35:44 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2025-01-22 | Sell | 865 | 18.94 | 16,384 | 2025-01-23 20:33:26 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2025-01-22 | Sell | 925 | 18.94 | 17,520 | 2025-01-23 20:31:02 |
| TVTX | Travere Therapeutics, Inc. | Inrig Jula | CHIEF MEDICAL OFFICER | 2025-01-03 | Sell | 2,506 | 19.04 | 47,715 | 2025-01-06 19:21:02 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2024-12-26 | Sell | 15,000 | 17.22 | 258,278 | 2024-12-27 19:47:04 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2024-12-26 | Option Exercise | 15,000 | 12.67 | 190,050 | 2024-12-27 19:47:04 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2024-11-25 | Sell | 12,090 | 18.30 | 221,258 | 2024-11-25 21:00:49 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2024-11-25 | Option Exercise | 15,000 | 12.67 | 190,050 | 2024-11-25 21:00:49 |
| TVTX | Travere Therapeutics, Inc. | LYONS GARY A | Directior | 2024-10-04 | Sell | 40,000 | 14.73 | 589,101 | 2024-10-04 19:15:51 |
| TVTX | Travere Therapeutics, Inc. | LYONS GARY A | Directior | 2024-10-04 | Option Exercise | 40,000 | 10.48 | 419,200 | 2024-10-04 19:15:51 |
| TVTX | Travere Therapeutics, Inc. | Meckler Jeffrey A | Directior | 2024-09-30 | Sell | 40,000 | 14.06 | 562,324 | 2024-09-30 20:38:12 |
| TVTX | Travere Therapeutics, Inc. | Meckler Jeffrey A | Directior | 2024-09-30 | Option Exercise | 40,000 | 10.48 | 419,200 | 2024-09-30 20:38:12 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2024-04-11 | Sell | 54 | 6.74 | 364 | 2024-04-12 16:05:08 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | CHIEF EXECUTIVE OFFICER | 2024-01-31 | Sell | 19,122 | 8.70 | 166,435 | 2024-02-02 16:06:01 |
| TVTX | Travere Therapeutics, Inc. | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | 2024-01-31 | Sell | 4,764 | 8.71 | 41,495 | 2024-02-02 16:05:41 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2024-01-31 | Sell | 2,820 | 8.53 | 24,058 | 2024-02-02 16:05:37 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | 2024-01-31 | Sell | 4,764 | 8.71 | 41,495 | 2024-02-02 16:05:35 |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | CHIEF COMMERCIAL OFFICER | 2024-01-31 | Sell | 4,195 | 8.53 | 35,789 | 2024-02-02 16:05:34 |
| TVTX | Travere Therapeutics, Inc. | Inrig Jula | CHIEF MEDICAL OFFICER | 2024-01-31 | Sell | 2,174 | 8.53 | 18,547 | 2024-02-02 16:05:27 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2024-01-31 | Sell | 3,818 | 8.53 | 32,573 | 2024-02-02 16:05:22 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | 2024-01-23 | Sell | 2,062 | 8.96 | 18,476 | 2024-01-25 16:10:27 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | CHIEF EXECUTIVE OFFICER | 2024-01-23 | Sell | 7,873 | 8.96 | 70,542 | 2024-01-25 16:10:21 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2024-01-23 | Sell | 853 | 9.07 | 7,735 | 2024-01-25 16:10:17 |
| TVTX | Travere Therapeutics, Inc. | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | 2024-01-23 | Sell | 2,062 | 8.96 | 18,476 | 2024-01-25 16:10:16 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2024-01-23 | Sell | 910 | 9.07 | 8,252 | 2024-01-25 16:10:12 |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | CHIEF COMMERCIAL OFFICER | 2024-01-23 | Sell | 1,559 | 9.07 | 14,138 | 2024-01-25 16:10:11 |
| TVTX | Travere Therapeutics, Inc. | Inrig Jula | Chief Medical Officer | 2024-01-03 | Sell | 2,509 | 9.43 | 23,648 | 2024-01-05 16:11:49 |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Officer | 2023-10-03 | Sell | 3,091 | 8.25 | 25,504 | 2023-10-04 16:05:09 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | Chief Financial Officer | 2023-09-05 | Sell | 457 | 14.71 | 6,723 | 2023-09-05 20:15:39 |
| TVTX | Travere Therapeutics, Inc. | ROTE WILLIAM E. | Senior Vice President, R&D | 2023-08-31 | Sell | 1,815 | 14.71 | 26,699 | 2023-09-05 20:13:54 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & Corporate Secretary | 2023-08-31 | Sell | 1,815 | 14.71 | 26,699 | 2023-09-05 20:12:15 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | 2023-08-31 | Sell | 4,455 | 14.71 | 65,533 | 2023-09-05 20:10:08 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | Chief Financial Officer | 2023-05-10 | Sell | 455 | 16.59 | 7,548 | 2023-05-12 16:14:19 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & Corporate Secretary | 2023-05-10 | Sell | 825 | 16.59 | 13,687 | 2023-05-12 16:11:57 |
| TVTX | Travere Therapeutics, Inc. | ROTE WILLIAM E. | Senior Vice President, R&D | 2023-05-10 | Sell | 825 | 16.59 | 13,687 | 2023-05-12 16:09:22 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, Chief Accounting Officer | 2023-05-10 | Sell | 558 | 16.49 | 9,200 | 2023-05-12 16:06:20 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | Chief Financial Officer | 2023-04-11 | Sell | 47 | 21.49 | 1,010 | 2023-04-13 16:07:27 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & Corporate Secretary | 2023-01-31 | Sell | 2,590 | 22.25 | 57,628 | 2023-02-02 19:11:10 |
| TVTX | Travere Therapeutics, Inc. | ROTE WILLIAM E. | Senior Vice President, R&D | 2023-01-31 | Sell | 2,590 | 22.25 | 57,628 | 2023-02-02 19:08:39 |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Officer | 2023-01-31 | Sell | 1,779 | 21.75 | 38,697 | 2023-02-02 19:04:53 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | Chief Financial Officer | 2023-01-31 | Sell | 1,588 | 21.75 | 34,542 | 2023-02-02 19:02:35 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | 2023-01-31 | Sell | 8,196 | 22.25 | 182,361 | 2023-02-02 18:58:33 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, Chief Accounting Officer | 2023-01-31 | Sell | 2,031 | 21.87 | 44,419 | 2023-02-02 18:53:33 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, Chief Accounting Officer | 2023-01-24 | Sell | 1,097 | 21.86 | 23,976 | 2023-01-26 16:05:49 |
| TVTX | Travere Therapeutics, Inc. | ROTE WILLIAM E. | Senior Vice President, R&D | 2023-01-24 | Sell | 2,062 | 21.50 | 44,333 | 2023-01-26 16:05:48 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & Corporate Secretary | 2023-01-24 | Sell | 2,062 | 21.50 | 44,333 | 2023-01-26 16:05:38 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | 2023-01-24 | Sell | 6,442 | 21.50 | 138,503 | 2023-01-26 16:05:36 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | Chief Financial Officer | 2023-01-24 | Sell | 852 | 21.90 | 18,663 | 2023-01-26 16:05:28 |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Officer | 2023-01-24 | Sell | 1,550 | 21.90 | 33,952 | 2023-01-26 16:05:20 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | 2023-01-05 | Sell | 5,625 | 20.75 | 116,719 | 2023-01-06 16:05:56 |
| TVTX | Travere Therapeutics, Inc. | Inrig Jula | Chief Medical Officer | 2023-01-04 | Sell | 2,493 | 20.75 | 51,730 | 2023-01-06 16:05:16 |
